Pan Tumor Rollover Study

Inclusion Criteria:

• Signed Written Informed Consent.

• Eligible to receive continued study treatment per the Parent Study, includingtreatment beyond progression per investigator assessment in the Parent Study.

• On treatment hold in the Parent Study following long-lasting response or areeligible for treatment rechallenge as defined in the Parent Study.

• WOCBP and male participants who are sexually active must agree to followinstructions for method(s) of contraception as described below and included in theICF.

Exclusion Criteria:

• Participant is not eligible for study treatment per the Parent Study eligibilitycriteria.

• Participants not receiving clinical benefit as assessed by the Investigator.

• Any clinical adverse event (AE), laboratory abnormality, or intercurrent illnesswhich, in the opinion of the Investigator, indicates that participation in the studyis not in the best interest of the participant.

• Other protocol-defined Inclusion/Exclusion Criteria apply